downtown phoenix at night

35th Annual GRAL Conference

Course Goal

To promote international collaboration to further research on the diagnosis and treatment of age-related neurological disorders.

Course Learning Objectives

  • To advance knowledge of brain function in normal and pathological aging
  • To present strategies for health promotion and prevention of neurological disease/damage
  • To demonstrate the trajectory of recovery from brain injury in aging individuals 
  • To characterize cognitive and functional decline in individuals with age-related neurodegenerative disease
  • To promote understanding of novel therapeutic interventions for age-related neurological disease

Registration Information

Attendee Typeprice
Registration for 3 Days$450
Registration for 2 Days$350
Registration for 1 Day$250
gral conference web banner

Date, Time, and Location

In Person
Thursday – Saturday, January 25-27, 2024

Barrow Neurological Institute
2910 North 3rd Avenue
Phoenix, Arizona 85013
Scroll down for campus map

Target Audience

This program is designed for physicians, neuropsychologists, psychologists, neuroscience researchers, physician assistants, and nurse practitioners.

Agenda & Speaker Information

All times refer to Arizona time.

SPeakerTopic & Time
Day 1Thursday, January 25, 2024
Coffee and Breakfast 8:00 AM
Yonas E. Geda, MD, MSc (Phoenix, Arizona)Opening Ceremony (8:30 AM)
Danielle Eagan, PhD, ABPP (Phoenix, Arizona)
Welcome to GRAL (8:35 AM)
Michael Lawton, MD (Barrow CEO; Phoenix, Arizona)Welcome To Barrow Neurological Institute (8:40 AM)
Bernard François Michel, MD (Marseille, France)Brief History of GRAL (8:45 AM)
Bruce Price, MD (McLean Hospital, Boston, Massachusetts)Behavioral Neurology, Neuropsychiatry, and Beyond: Where do we go from here? (9:00 AM)
Normal Aging 10:00 AM
Gregory A. Jicha, MD, PhD (Lexington, Kentucky)The Neurobiology of Aging (10:00 AM)
Nicoletta Caputi, PhD (Rome, Italy)Physiological Cognitive Changes in Aging and How to Prevent Cognitive Decline
(10:45 AM)
Francois Boller, MD, PhD (Washington DC, Paris France)Q&A (11:15 AM)
Mild Cognitive Impairment11:30 PM
Ronald C. Petersen, MD, PhD (Rochester, Minnesota)Mild Cognitive Impairment 2024: Diagnosis and Treatment (11:30 PM)
Susan Hernes, MD, PhD (Bergen, Norway)Preliminary Results from the REACT MCI Study (12:15 PM)
Per Kristian Eide, MD, PhDGlymphatic and Meningeal Lymphatic Clearance of Substances from Human Brain: Possible Implications for Neurodegenerative Disease (12:45 PM)
Yonas E. Geda, MD, MSc (Phoenix, Arizona)Q&A (1:15 PM)
Lunch1:30 PM
Traumatic Brain Injury2:00 PM
Michael Alosco, PhD (Boston, Massachusetts)Traumatic Encephalopathy 
Syndrome/CTE NIDS Criteria (2:00 PM)
Bernard François Michel, MD (Marseille, France)PTSD in TBI (2:45 PM)
Glynnis Zieman, MD (Phoenix, Arizona)  Domestic Violence, Aging, and TBI (3:15 PM)
Javier Cardenas, MD (Morgantown, West Virginia)Q&A (3:45 PM)
DinnerSeasons 52 (6:00 PM)
2502 E Camelback Rd. Suite 140, 85016
Day 2 Friday, January 26, 2023
Coffee and Breakfast8:00 AM
Brad A. Racette, MD (Phoenix, Arizona)The Neurological Health Effects of Your Tesla (Grand Rounds) (8:30 AM)
Richard Levy, MD, PhD (Paris, France)The Prefrontal Cortex: From Monkey to Man (9:30 AM)
Holly Shill, MD (Phoenix, Arizona)Parkinson’s Disease: How Genetics is Informing Diagnosis and Treatment (10:15 AM)
Oury Monchi, PhDNon-Motor Symptoms in Parkinson’s Disease: Neuroimaging and Behavioral Studies (10:45 AM)
Alexander Troster, PhD, ABPP-CN (Phoenix, Arizona)Q&A (11:15 AM)
Lunch & Poster Session 11:30 AM
Poster Session
Dr. Gizachew Yismaw WubetuThe Design and Conduct of a Plot Project on Mild Cognitive Impairment in Bahir Dar, Ethiopia
Ms. Mari SchibstadEngaging the Silver Generation: Leveraging Internet and Multimedia for Recruiting Older Adults to Intervention Studies
Trine Holt Edwin, MD, PhDTrajectories of Occupational Cognitive Demands and Risk of Clinically-Assessed Mild Cognitive Impairment and Dementia in Later Life
Geetika Chahal, MBBS
Jessica Baez Cruz, B.S.
Danielle Eagan, PhD, ABPP
Yonas E. Geda, MD, MSc.
The Design and Conduct of a Brain Health Research Program: A Feasibility Study
Alzheimer’s Disease and Related Disorders 12:00 PM
Anna Burke, MD (Phoenix, Arizona)Addressing the Growing Alzheimer’s Crisis; Challenges and Opportunities (12:00 PM)
Justin Hoskin, MD (Phoenix, Arizona)Cognitive Impairment in Normal Pressure Hydrocephalus (12:45 PM)
Parunyou Julayanont, MD (Phoenix, Arizona)Alzheimer’s Disease and Atypical Alzheimer’s Disease Syndromes (1:15 PM)
George Prigatano, PhD (Phoenix, Arizona)Love and Primary Progressive Aphasia (1:45 PM)
Krista Hanson, PhD, ABPP-CN (Phoenix, Arizona)Q&A (2:15 PM)
Therapeutic Approaches2:30 PM
Jeffrey L Cummings, MD, ScDAlzheimer’s Disease: The Changing Therapeutic Landscape (2:30 PM)
Marwan Sabbagh, MD (Phoenix, Arizona)Applying Translational Medicine to Repurpose Cancer Drugs for Alzheimer’s Disease (3:15 PM)
Joseph Masdeu, MD, PhD (Houston, Texas)Anti-Amyloid Monoclonals: Most Effective in the Pre-Symptomatic Stage (3:45 PM)
Bernard François Michel, MD (Marseille, France)Q&A (4:15 PM)
Evening ReceptionHeard Museum (6:00 PM)
2301 N Central Ave., 85004
Day 3Saturday, January 27, 2023
Coffee and Breakfast8:00 AM
Cerebrovascular & White Matter Diseases8:30 AM
Christopher Filley, MD (Aurora, Colorado)White Matter Dementia Then and Now (8:30 AM)
Gustavo C. Roman, MDThe Fourth Circulation: The Importance of Glymphatic Circulation in Sleep, Dementia, and Cerebrovascular Disease (9:15 AM)
Anne-Marie Ergis, PhDMultiple Sclerosis and Aging (9:45 AM)
Travis McCuddy, PhD (Phoenix, Arizona)DTI Tractography and Cognitive Impairment Impairment in Vascular Dementia (10:15 AM)
Danielle Eagan, PhD, ABPP (Phoenix, Arizona)Q&A and Closing Remarks (10:45 AM)

International Scientific Committee

Bernard Francois Michel, MD
Chief Medical Officer Neurologist
Military Training Hospital Laveran Marseille, France

Yonas E. Geda, MD, MSc
Vice President, Groupe de Recherche sur la maladie d’Alzheimer (GRAL)
Professor and Program Director, Behavioral Neurology & Neuropsychiatry Fellowship Program, Barrow Neurological Institute

Francois Boller, MD, PhD
Clinical Professor of Neurology and Rehabilitation Medicine
George Washington School of Medicine & Health Sciences, Washington DC

Nicoletta Caputi, PhD
Fellow at George Washington University and University of L’Aquila, Italy

Ann-Marie Ergis, PhD
Professor at Paris Descartes, CPSC, France

Gabor G. Kovacs, MD, PhD
Professor in the Department of Laboratory Medicine & Pathobiology
University of Toronto, Canada

Bruce Price, MD
Chief, Department of Neurology, McLean Hospital, Belmont Massachusetts

Exhibitors and Sponsors

  • Exhibitor and sponsor information coming soon.


Barrow Neurological Institute campus in 3D